Humacyte PT receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Symbol | Exchange | Currency |
|---|
Investing.com - Humacyte reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Humacyte announced earnings per...
Humacyte, Inc. (HUMA) reported Q3 EPS of ($0.25), $0.02 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $30 thousand versus the consensus estimate of...
Humacyte, Inc. is engaged in the development and manufacturing of off-the-shelf, universally implantable, bioengineered human tissues. It is developing a portfolio of human acellular vessels (HAVs) with varying diameters and lengths. The HAV cabinet would initially target the vascular repair, reconstruction and replacement market, including vascular trauma; atrioventricular (AV) access for hemodialysis; peripheral arterial disease (PAD); and coronary artery bypass grafting (CABG). The Company has developed a paradigm for manufacturing human tissues that is intended to mimic key aspects of human physiology. It is developing and manufacturing acellular tissues to address life- and limb-threatening vascular conditions while focusing on potential future applications for complex tissue and organ diseases. It is also engaged in developing its HAVs for pediatric heart surgery and the delivery of cellular therapies, including pancreatic islet cell transplantation to treat Type 1 diabetes.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Sell |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 94.55 | 94.70 | 91.68 | +2.72 | +2.96% | 14.60M | NYSE | |||
| 267.56 | 268.77 | 260.08 | +10.79 | +4.20% | 50.36M | NASDAQ | |||
| 70.98 | 71.41 | 68.73 | -0.03 | -0.04% | 6.48M | NYSE | |||
| 196.81 | 197.50 | 189.55 | +2.05 | +1.05% | 185.07M | NASDAQ | |||
| 43.59 | 43.90 | 43.25 | -0.17 | -0.39% | 22.95M | NYSE | |||
| 122.97 | 123.69 | 113.48 | +13.69 | +12.53% | 5.74M | NASDAQ | |||
| 29.05 | 29.27 | 28.43 | +0.36 | +1.25% | 50.50M | NASDAQ | |||
| 228.46 | 230.11 | 219.56 | +5.47 | +2.45% | 5.39M | NASDAQ | |||
| 4.67 | 4.80 | 4.642 | -0.200 | -4.11% | 29.27M | NYSE | |||
| 33.53 | 33.59 | 32.35 | +0.92 | +2.82% | 3.59M | NYSE | |||
| 37.56 | 37.59 | 37.01 | -0.01 | -0.03% | 3.55M | NYSE | |||
| 13.45 | 13.51 | 12.98 | +0.31 | +2.36% | 70.14M | NYSE | |||
| 319.10 | 319.78 | 305.78 | +7.78 | +2.50% | 1.26M | NASDAQ | |||
| 47.18 | 47.31 | 44.67 | +2.20 | +4.89% | 3.60M | NYSE | |||
| 769.94 | 778.05 | 763.15 | -10.92 | -1.40% | 885.34K | NASDAQ |